FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2779-2787 December 29, 2005 Number 26 Next

	Full Text PDF PDA Full Text Editorial by Drazen, J. M. Editorial by Haug, C. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Clinical trial registration allows interested parties to obtain information about ongoing and completed trials, but there are few data indicating the quality of the information provided during the registration process. We used information in the publicly available ClinicalTrials.gov database to describe patterns of trial registration before and after the implementation by journal editors of a new policy requiring registration as a prerequisite for publication.

Methods We reviewed ClinicalTrials.gov records to determine patterns of completion of the "Intervention Name" and "Primary Outcome Measure" data fields for trials registered on May 20 and October 11, 2005, and for trials registered during the interval between these two dates, inclusively.

Results During the interval studied, the number of registrations in ClinicalTrials.gov increased by 73 percent from 13,153 to 22,714. The percentage of interventional trials registered by industry with nonspecific Intervention Name entries (attributable to four drug companies) decreased from 10 percent to 2 percent; all other industry and nonindustry records contained specific entries in this field. Of the 2670 studies registered by industry between the two dates, 76 percent provided information in the Primary Outcome Measure field, although these entries varied markedly in their degree of specificity. In the remaining 24 percent of the records, this field was blank.

Conclusions During the summer of 2005, there were large increases in the number of clinical trial registrations. Overall, the data contained in records were more complete in October than they were in May, but there still is room for substantial improvement.

Source Information

From the Lister Hill National Center for Biomedical Communications, National Library of Medicine, National Institutes of Health, Bethesda, Md.

Address reprint requests to Dr. Zarin at the National Library of Medicine, Bldg. 38A, National Institutes of Health, 8600 Rockville Pike, Bethesda, MD 20894, or at dzarin{at}mail.nih.gov.

Full Text of this Article

Related Letters:

Clinical Trials Report Card
Feczko J., Johnson K., Lassere M., Krall R. L., Rockhold F., Tamir O., Lipschitz Y., Shemer J., Reidenberg M. M., Zarin D. A., Tse T., Ide N. C., Drazen J. M., Wood A. J.J., Haug C., Gøtzsche P. C., Schroeder T. V.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:1426-1429, Mar 30, 2006. Correspondence

This article has been cited by other articles:

• Mathieu, S., Boutron, I., Moher, D., Altman, D. G., Ravaud, P. (2009). Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials. JAMA 302: 977-984 [Abstract] [Full Text]  
• Guo, S.-W., Hummelshoj, L., Olive, D. L., Bulun, S. E., D'Hooghe, T. M., Evers, J. L.H. (2009). A call for more transparency of registered clinical trials on endometriosis. Hum Reprod 24: 1247-1254 [Abstract] [Full Text]  
• Conen, D., Torres, J., Ridker, P. M (2008). Differential Citation Rates of Major Cardiovascular Clinical Trials According to Source of Funding: A Survey From 2000 to 2005. Circulation 118: 1321-1327 [Abstract] [Full Text]  
• Kim, D., Labkoff, S., Holliday, S. H. (2008). Opportunities for Electronic Health Record Data to Support Business Functions in the Pharmaceutical Industry--A Case Study from Pfizer, Inc.. J. Am. Med. Inform. Assoc. 15: 581-584 [Abstract] [Full Text]  
• Kopetz, S., Overman, M., Chang, D. Z., Glover, K. Y., Shureiqi, I., Wolff, R. A., Abbruzzese, J. L., Eng, C. (2008). Systematic Survey of Therapeutic Trials for Metastatic Colorectal Cancer: Room for Improvement in the Critical Pathway. JCO 26: 2000-2005 [Abstract] [Full Text]  
• Laine, C., De Angelis, C., Delamothe, T., Drazen, J. M., Frizelle, F. A., Haug, C., Hebert, P. C., Horton, R., Kotzin, S., Marusic, A., Sahni, P., Schroeder, T. V., Sox, H. C., Van Der Weyden, M. B., Verheugt, F. W.A. (2007). Clinical Trial Registration: Looking Back and Moving Ahead. ANN INTERN MED 147: 275-277 [Full Text]  
• Laine, C., Horton, R., DeAngelis, C. D., Drazen, J. M., Frizelle, F. A., Godlee, F., Haug, C., Hebert, P. C., Kotzin, S., Marusic, A., Sahni, P., Schroeder, T. V., Sox, H. C., Van Der Weyden, M. B., Verheugt, F. W.A. (2007). Clinical Trial Registration: Looking Back and Moving Ahead. JAMA 298: 93-94 [Full Text]  
• Laine, C. MD MPH, Horton, R. FMedSci, DeAngelis, C. D. MD MPH, Drazen, J. M. MD, Frizelle, F. A. MBChB MMed, Godlee, F. MBBChir BS, Haug, C. MD PhD MSc, Hebert, P. C. MD MHSc, Kotzin, S. MLS, Marusic, A. MD PhD, Sahni, P. MS PhD, Schroeder, T. V. MD DMSc, Sox, H. C. MD, Van Der Weyden, M. B. MD, Verheugt, F. W.A. MD (2007). Clinical trial registration: looking back and moving ahead. CMAJ 177: 57-58 [Full Text]  
• Laine, C., Horton, R., DeAngelis, C. D., Drazen, J. M., Frizelle, F. A., Godlee, F., Haug, C., Hebert, P. C., Kotzin, S., Marusic, A., Sahni, P., Schroeder, T. V., Sox, H. C., Van Der Weyden, M. B., Verheugt, F. W.A. (2007). Clinical Trial Registration -- Looking Back and Moving Ahead. NEJM 356: 2734-2736 [Full Text]  
• Laine, C., Horton, R., DeAngelis, C. D, Drazen, J. M, Frizelle, F. A, Godlee, F., Haug, C., Hebert, P. C, Kotzin, S., Marusic, A., Sahni, P., Schroeder, T. V, Sox, H. C, Weyden, M. B V. D., Verheugt, F. W A (2007). Clinical trial registration. BMJ 334: 1177-1178 [Full Text]  
• Zarin, D. A., Ide, N. C., Tse, T., Harlan, W. R., West, J. C., Lindberg, D. A. B. (2007). Issues in the Registration of Clinical Trials. JAMA 297: 2112-2120 [Abstract] [Full Text]  
• Coultas, D. (2007). Ethical Considerations in the Interpretation and Communication of Clinical Trial Results. Proc Am Thorac Soc 4: 194-199 [Abstract] [Full Text]  
• Zarin, D. A., Keselman, A. (2007). Registering a Clinical Trial in ClinicalTrials.gov. Chest 131: 909-912 [Full Text]  
• Liebeskind, D. S., Kidwell, C. S., Sayre, J. W., Saver, J. L. (2006). Evidence of publication bias in reporting acute stroke clinical trials.. Neurology 67: 973-979 [Abstract] [Full Text]  
• Benjamin, D. K. Jr, Smith, P. B., Murphy, M. D., Roberts, R., Mathis, L., Avant, D., Califf, R. M., Li, J. S. (2006). Peer-reviewed publication of clinical trials completed for pediatric exclusivity.. JAMA 296: 1266-1273 [Abstract] [Full Text]  
• Boyle, A. J., Schulman, S. P., Hare, J. M. (2006). Stem Cell Therapy for Cardiac Repair: Ready for the Next Step. Circulation 114: 339-352 [Full Text]  
• Ridker, P. M, Torres, J. (2006). Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.. JAMA 295: 2270-2274 [Abstract] [Full Text]  
• Feczko, J., Johnson, K., Lassere, M., Krall, R. L., Rockhold, F., Tamir, O., Lipschitz, Y., Shemer, J., Reidenberg, M. M., Zarin, D. A., Tse, T., Ide, N. C., Drazen, J. M., Wood, A. J.J., Haug, C., Gotzsche, P. C., Schroeder, T. V. (2006). Clinical trials report card.. NEJM 354: 1426-1429 [Full Text]  
• Drazen, J. M., Wood, A. J.J. (2005). Trial Registration Report Card. NEJM 353: 2809-2811 [Full Text]  
• Haug, C., Gotzsche, P. C., Schroeder, T. V. (2005). Registries and Registration of Clinical Trials. NEJM 353: 2811-2812 [Full Text]